Overview

Study of Antidepressants in Parkinson's Disease

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor symptoms of Parkinson's disease such as tremor, stiffness, slowness, and balance.
Phase:
Phase 3
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Antidepressive Agents
Paroxetine
Venlafaxine Hydrochloride